UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Cell Competition During Growth and Regeneration

Annual review of genetics, 2015-11, Vol.49 (1), p.697-718

2015

Link zum Volltext

Verfügbarkeit prüfen

Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy

PloS one, 2019-11, Vol.14 (11), p.e0224267

2019

Link zum Volltext

Verfügbarkeit prüfen

Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer

The Journal of experimental medicine, 2018-03, Vol.215 (3), p.895-910

2018

Link zum Volltext

Verfügbarkeit prüfen

Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer

Molecular oncology, 2019-08, Vol.13 (8), p.1778-1794

2019

Link zum Volltext

Verfügbarkeit prüfen

MP10-08 PHENOTYPING PATIENTS WITH NEPHROLITHIASIS: CAN WE PREDICT ABNORMAL 24-HOUR URINE PARAMETERS BASED ON INITIAL STONE PRESENTATION?

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Link zum Volltext

Verfügbarkeit prüfen

Voided volume may not impact stone outcomes: Review of a large institutional nephrolithiasis cohort

BJUI compass, 2023-09, Vol.4 (5), p.556-561

2023

Link zum Volltext

Verfügbarkeit prüfen

Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial

Advances in radiation oncology, 2022-09, Vol.7 (5), p.100941-100941, Article 100941

2022

Link zum Volltext

Verfügbarkeit prüfen

Nedosiran Dramatically Reduces Serum Oxalate in Dialysis-Dependent Primary Hyperoxaluria 1: A Compassionate Use Case Report

Urology (Ridgewood, N.J.), 2021-10, Vol.156, p.e147-e149

2021

Link zum Volltext

Verfügbarkeit prüfen

PD34-05 A NOVEL MACHINE-LEARNING ALGORITHM TO PREDICT STONE RECURRENCE WITH 24-HOUR URINE DATA

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Link zum Volltext

Verfügbarkeit prüfen

Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin

Case reports in oncology, 2016-12, Vol.9 (3), p.840-846

2016

Link zum Volltext

Verfügbarkeit prüfen

PD46-08 FOLLOWING THE CROWD: PATTERNS OF CROWDSOURCING ON SOCIAL MEDIA AMONG UROLOGISTS

The Journal of urology, 2017-04, Vol.197 (4), p.e893-e893

2017

Link zum Volltext

Verfügbarkeit prüfen

MP45-05 MICRORNA 185-5P IS A NOVEL BIOMARKER ASSOCIATED WITH HIGH-RISK PATHOLOGY AT RADICAL PROSTATECTOMY IN PATIENTS WITH LOW-RISK DISEASE AT DIAGNOSIS

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Link zum Volltext

Verfügbarkeit prüfen

MP21-13 LOWER SOCIOECONOMIC STATUS IS ASSOCIATED WITH HIGHER URINARY SODIUM: IMPLICATIONS FOR DIETARY STONE GUIDANCE IN UNDERSERVED COMMUNITIES

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Link zum Volltext

Verfügbarkeit prüfen

Following the crowd: patterns of crowdsourcing on Twitter among urologists

World journal of urology, 2019-03, Vol.37 (3), p.567-572

2019

Link zum Volltext

Verfügbarkeit prüfen

Formal Mentorship as an Opportunity to Expand the Urology Pipeline: Under Represented Trainees Entering Residency (UReTER) Program Evaluation 2020–2021

Urology (Ridgewood, N.J.), 2022-04, Vol.162, p.108-113

2022

Link zum Volltext

Verfügbarkeit prüfen

Limited relevance of the “very low risk” prostate cancer classification in the modern era: Results from a large institutional active surveillance cohort

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.381-381

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant

The oncologist (Dayton, Ohio), 2021-06, Vol.26 (6), p.467-e924

2021

Link zum Volltext

Verfügbarkeit prüfen

MP47-17 NEDOSIRAN DRAMATICALLY REDUCES SERUM OXALATE IN DIALYSIS-DEPENDENT PRIMARY HYPEROXALURIA 1: A COMPASSIONATE USE CASE REPORT

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Link zum Volltext

Verfügbarkeit prüfen

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

Nature (London), 2012-07, Vol.487 (7408), p.500-504

2012

Link zum Volltext

Verfügbarkeit prüfen

DOES GENOMIC RISK SCORE AT BIOPSY CORRELATE WITH FOCALITY OF DISEASE AT RADICAL PROSTATECTOMY: IMPLICATIONS FOR FOCAL THERAPY CANDIDATES

Urologic oncology, 2024-03, Vol.42, p.S80-S80

2024

Link zum Volltext

Verfügbarkeit prüfen

PD13-01 DETERMINING LONG-TERM PROSTATE CANCER OUTCOMES FOR ACTIVE SURVEILLANCE PATIENTS WITHOUT EARLY DISEASE PROGRESSION: WHEN TO SLOW OR STOP SURVEILLANCE

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Link zum Volltext

Verfügbarkeit prüfen

P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer

Oncogene, 2015-07, Vol.34 (30), p.3968-3976

2015

Link zum Volltext

Verfügbarkeit prüfen

MP11-09 PRIOR EXPERIENCE IN ATHLETICS IS SIGNIFICANTLY ASSOCIATED WITH INCREASED ROBOTIC SURGICAL SKILL IN ROBOT-NAIVE MEDICAL STUDENTS

The Journal of urology, 2016-04, Vol.195 (4), p.e114-e115

2016

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers to diagnose metastatic breast carcinoma to the pancreas: A case report and update

Diagnostic cytopathology, 2019-09, Vol.47 (9), p.912-917

2019

Link zum Volltext

Verfügbarkeit prüfen

Readability analysis of online health information about overactive bladder

Neurourology and urodynamics, 2017-09, Vol.36 (7), p.1782-1787

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 77

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(76)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(38)
Humans
(27)
Female
(18)
Oncology
(17)
Animals
(10)
Breast Cancer
(10)
Breast Neoplasms - Pathology
(9)
Mice
(8)
Urology & Nephrology
(8)
Breast Neoplasms - Drug Therapy
(7)
Breast Neoplasms - Metabolism
(7)
Mutation
(7)
Breast Neoplasms - Genetics
(6)
Cancer
(6)
Cell Line, Tumor
(6)
Medicine
(6)
Tumors
(6)
Analysis
(5)
Antineoplastic Agents - Pharmacology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cell Competition During Growth and Regeneration

Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy

Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer

Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer

MP10-08 PHENOTYPING PATIENTS WITH NEPHROLITHIASIS: CAN WE PREDICT ABNORMAL 24-HOUR URINE PARAMETERS BASED ON INITIAL STONE PRESENTATION?

Voided volume may not impact stone outcomes: Review of a large institutional nephrolithiasis cohort

Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial

Nedosiran Dramatically Reduces Serum Oxalate in Dialysis-Dependent Primary Hyperoxaluria 1: A Compassionate Use Case Report

PD34-05 A NOVEL MACHINE-LEARNING ALGORITHM TO PREDICT STONE RECURRENCE WITH 24-HOUR URINE DATA

Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin

PD46-08 FOLLOWING THE CROWD: PATTERNS OF CROWDSOURCING ON SOCIAL MEDIA AMONG UROLOGISTS

MP45-05 MICRORNA 185-5P IS A NOVEL BIOMARKER ASSOCIATED WITH HIGH-RISK PATHOLOGY AT RADICAL PROSTATECTOMY IN PATIENTS WITH LOW-RISK DISEASE AT DIAGNOSIS

MP21-13 LOWER SOCIOECONOMIC STATUS IS ASSOCIATED WITH HIGHER URINARY SODIUM: IMPLICATIONS FOR DIETARY STONE GUIDANCE IN UNDERSERVED COMMUNITIES

Following the crowd: patterns of crowdsourcing on Twitter among urologists

Formal Mentorship as an Opportunity to Expand the Urology Pipeline: Under Represented Trainees Entering Residency (UReTER) Program Evaluation 2020–2021

Limited relevance of the “very low risk” prostate cancer classification in the modern era: Results from a large institutional active surveillance cohort

Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant

MP47-17 NEDOSIRAN DRAMATICALLY REDUCES SERUM OXALATE IN DIALYSIS-DEPENDENT PRIMARY HYPEROXALURIA 1: A COMPASSIONATE USE CASE REPORT

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

DOES GENOMIC RISK SCORE AT BIOPSY CORRELATE WITH FOCALITY OF DISEASE AT RADICAL PROSTATECTOMY: IMPLICATIONS FOR FOCAL THERAPY CANDIDATES

PD13-01 DETERMINING LONG-TERM PROSTATE CANCER OUTCOMES FOR ACTIVE SURVEILLANCE PATIENTS WITHOUT EARLY DISEASE PROGRESSION: WHEN TO SLOW OR STOP SURVEILLANCE

P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer

MP11-09 PRIOR EXPERIENCE IN ATHLETICS IS SIGNIFICANTLY ASSOCIATED WITH INCREASED ROBOTIC SURGICAL SKILL IN ROBOT-NAIVE MEDICAL STUDENTS

Biomarkers to diagnose metastatic breast carcinoma to the pancreas: A case report and update

Readability analysis of online health information about overactive bladder

Aktive Filter

Suchergebnisse filtern